Make a donation today.
Help to find a cure.

Anders 15 months old

Other treatments, have been used in DBA over the last 30 years. These drugs appear to be largely ineffective and there is currently no evidence that any of these has a major role in the management of DBA. (Vlachos et al, 2008; Geller et al, 1975; Dunbar et al, 1991; Fiorillo et al, 1991; Niemeyer et al, 1991; Gomez-Almaguer & Gonzalez-Llano, 1992; Sumimoto et al, 1992; Bejaoui et al, 1993; Gillio et al, 1993a, 1993b; Bastion et al, 1994; Brown et al, 1994; Olivieri et al, 1994; Ozsoylu, 1994; Ball et al, 1995; Bernini et al, 1995; Buchanan, 2001; Alter, 2003)
Summary of Alternative Therapies from the International Clinical Care Consensus Document:
| Treatments | Number of Patients | Response |
| Androgens | >100 | 20% |
| High dose corticosteroids | 12 | 7 |
| 8 | 3 complete, 1 partial | |
| 9 | 5 all transient | |
| Erythropoietin | 10 | 1 transient |
| Interleukin-3 | 100 | 10% |
| Cyclosporine ± prednisone | 20 (with steroids) | 50% all transient |
| 10 (CSA alone) | 2 sustained response | |
| Metoclopromide | 9 | 1 complete |
| 2 partial on steroid taper | ||
| 1 | 1 complete | |
| 33 | 2 partial | |
| Valproic acid | 1 | 1 complete |
| Leucine | 1 | 1 complete |
| Other (6-MP, cylcophosphamide, Vincristine, stem cell factor, PIXY 321, IVIG) | Largely ineffective |